1,3-Dichloro-4-[2-(8-hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]diazepin-3-yl)-ethyl]-5,6,7,8-tetrahydro-naphthalene-2-carboxylic acid

ID: ALA280097

PubChem CID: 10598361

Max Phase: Preclinical

Molecular Formula: C19H20Cl2N4O3

Molecular Weight: 423.30

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)c1c(Cl)c2c(c(CCn3cnc4c3NC=NCC4O)c1Cl)CCCC2

Standard InChI:  InChI=1S/C19H20Cl2N4O3/c20-15-11-4-2-1-3-10(11)12(16(21)14(15)19(27)28)5-6-25-9-24-17-13(26)7-22-8-23-18(17)25/h8-9,13,26H,1-7H2,(H,22,23)(H,27,28)

Standard InChI Key:  OGORQQICBKYNBE-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
    1.8917   -3.1917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3292   -3.6000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4667   -3.6125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1417   -2.6417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9542   -3.3042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4667   -4.2167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8625   -3.2917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4292   -3.6125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2917   -4.1917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9500   -4.5167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4292   -4.2167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7375   -2.7042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0042   -3.3167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3042   -3.2792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9042   -3.3042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8042   -4.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3875   -3.6042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2167   -4.3625    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0167   -2.7167    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.9792   -4.5167    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.9542   -2.7042    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    6.5250   -3.6292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9625   -2.7792    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0125   -3.8042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9417   -5.1167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9042   -4.5167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4167   -5.4250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9042   -5.1167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  5  2  0
  4  1  1  0
  5  8  1  0
  6 10  2  0
  7  2  1  0
  8 15  1  0
  9  2  1  0
 10 11  1  0
 11  8  2  0
 12  4  2  0
 13  3  1  0
 14  1  1  0
 15 17  1  0
 16  9  1  0
 17  7  1  0
 18 24  1  0
 19 13  2  0
 20  6  1  0
 21  5  1  0
 22 13  1  0
 23 14  1  0
 24 14  1  0
 25 10  1  0
 26 11  1  0
 27 28  1  0
 28 26  1  0
 12  7  1  0
 16 18  2  0
  6  3  1  0
 25 27  1  0
M  END

Associated Targets(Human)

AMPD3 Tchem AMP deaminase 3 (49 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

ADA Adenosine deaminase (739 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 423.30Molecular Weight (Monoisotopic): 422.0912AlogP: 3.50#Rotatable Bonds: 4
Polar Surface Area: 99.74Molecular Species: ACIDHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 2.24CX Basic pKa: 6.50CX LogP: 1.67CX LogD: 0.97
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.70Np Likeness Score: -0.10

References

1. Kasibhatla SR, Bookser BC, Xiao W, Erion MD..  (2001)  AMP deaminase inhibitors. 5. Design, synthesis, and SAR of a highly potent inhibitor series.,  44  (4): [PMID:11170651] [10.1021/jm000355t]

Source